Insulin efsitora alfa (efsitora) is a new basal insulin designed for once-weekly administration. Data on safety and efficacy have been limited to small, phase 1 or phase 2 trials. We conducted a ...

The authors say there has been a recent uptick in hosptial admissions from hypoglycemic events, and that a therapy to address this is needed. A review of 15 studies has found that insulin degludec, ...

Bagsværd, Denmark, 9 November 2012 Novo Nordisk today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the United States Food and Drug Administration (FDA) has completed its ...

Degludec vs glargine in type 2 diabetes Degludec is noninferior to glargine regarding the incidence of major cardiovascular events among patients with type 2 diabetes. Steven P. Marso, MD, from the ...

Insulin degludec (trade name: Tresiba) has been approved since January 2015 for adolescents and children from the age of one year with type 1 or type 2 diabetes mellitus. In an early benefit ...

The fixed combination of the two drugs insulin degludec and liraglutide (trade name: Xultophy) has been approved since June 2015 also in adults with type 2 diabetes mellitus when oral antidiabetics ...

A combination treatment containing ultra-long-acting insulin degludec and insulin aspart enhanced glucose control and reduced the risk of hypoglycemia, while insulin degludec alone also allowed for ...

San Diego, CA - The new longer-acting diabetes drug insulin degludec (Novo Nordisk) improves long-term glycemic control with a lower rate of nocturnal hypoglycemia compared with insulin glargine ...

Once-weekly efsitora noninferior to once-daily degludec for decrease in mean glycated hemoglobin level. (HealthDay News) — Once-weekly efsitora is noninferior to once-daily degludec for reducing ...

Combined insulin degludec/liraglutide lowers blood glucose and promotes weight loss without causing excess hypoglycemia among adults with type 2 diabetes who are not well-controlled using insulin ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio PHILADELPHIA — Insulin degludec is as ...

This material is intended for UK medical media only. For journalistic assessment and preparation before publication. New findings show that Xultophy® (insulin degludec/liraglutide; IDegLira), the ...